CogState Saham

CogState EPS

Delisted·15 Jun 2026

Laba per Saham (EPS) dari CogState (CGS.AX) pada 8 Agu 2026 adalah 0,06 USD. Tahun sebelumnya, Laba per Saham (EPS) adalah 0,03 USD — perubahan sebesar 85,17% (lebih tinggi).

EPS

0,06USD

YoY

85,17%

Terakhir Diperbarui:

Laba per Saham (EPS) dari CogState adalah 2026 0,06 USD. Laba per Saham (EPS) dari CogState adalah 2025 0,03 USD. Menurun 85,17% lebih tinggi dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

CogState Analisis saham

Apa yang dilakukan CogState? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham CogState

Laba per Saham (EPS) CogState adalah 0,06 USD pada tahun 2026.

Laba per Saham (EPS) dari CogState berubah dari 0,03 USD menjadi 0,06 USD, mewakili perubahan 85,17%. Nilainya lebih tinggi daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Laba per Saham (EPS) CogState sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Laba per Saham mengukur porsi laba perusahaan yang dialokasikan untuk setiap saham yang beredar. Metrik ini adalah metrik kunci untuk menilai profitabilitas perusahaan berdasarkan per saham.

EPS = Laba Bersih / Saham yang Beredar

Access this data via the Eulerpool API

Laporan Laba Rugi — CogState

Semua Metrik Kunci — CogState